BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8671866)

  • 1. Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
    Peces R; de la Torre M; Alcázar R
    Nephrol Dial Transplant; 1996 Apr; 11(4):707-8. PubMed ID: 8671866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Visceral leishmaniasis with cardiac affectation in an immunocompetent patient].
    Puerto-Alonso JL; Molina-Ruano FJ; Gómez-Soto F; Gómez-Rodríguez F
    Med Clin (Barc); 2006 Oct; 127(13):519. PubMed ID: 17043012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spontaneous rupture of the spleen in a patient with visceral leishmaniasis].
    Rovira RE; Díaz-Gómez JR; Lapuebla X; Aguar MC
    Enferm Infecc Microbiol Clin; 2005 May; 23(5):327. PubMed ID: 15899186
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal visceral disease caused by a dermotropic Leishmania in a patient with human immunodeficiency virus infection.
    Gradoni L; Gramiccia M; Betti F
    J Infect; 1990 Mar; 20(2):180-2. PubMed ID: 2319157
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral factors during South American visceral leishmaniasis.
    Pearson RD; Evans T; Wheeler DA; Naidu TG; De Alencar JE; Davis JS
    Ann Trop Med Parasitol; 1986 Aug; 80(4):465-8. PubMed ID: 3789849
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
    Faraut-Gambarelli F; Piarroux R; Deniau M; Giusiano B; Marty P; Michel G; Faugère B; Dumon H
    Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visceral kala-azar of Spanish origin. Apropos of a case].
    De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
    Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
    [No Abstract]   [Full Text] [Related]  

  • 12. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral leishmaniasis in an HIV-positive patient caused by two different zymodemes of Leishmania infantum.
    Cortés P; Cardeñosa N; Romaní J; Gállego M; Muñoz C; Barrio JL; Riera C; Portús M
    Trans R Soc Trop Med Hyg; 1997; 91(4):438-9. PubMed ID: 9373646
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel methods for the encapsulation of meglumine antimoniate into liposomes.
    Frézard F; Michalick MS; Soares CF; Demicheli C
    Braz J Med Biol Res; 2000 Jul; 33(7):841-6. PubMed ID: 10881061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis in a patient with human immunodeficiency virus.
    Rizzi M; Arici C; Bonaccorso C; Gavazzeni G
    Trans R Soc Trop Med Hyg; 1988; 82(4):565. PubMed ID: 3256108
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R; Rambaldi A; Tripodi MF; Andreana A
    Infection; 1995; 23(3):182-3. PubMed ID: 7499009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 18. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
    Moulin B; Ollier J; Bouchouareb D; Purgus R; Olmer M
    Nephron; 1992; 60(3):360-2. PubMed ID: 1565190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 7-month-old girl with fever and bleeding.
    Chaliasos N; Bourantas C; Kritikou E; Lapatsanis P
    Lancet; 1996 Apr; 347(9008):1086. PubMed ID: 8602061
    [No Abstract]   [Full Text] [Related]  

  • 20. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis].
    Nafil H; Tazi I; Mahmal L
    Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.